Abstract
Herein, we studied the effect of labile iron (ferric chloride) on the progression of liver cancer cells (HepG2.2.15). The iron was found to induce cell proliferation, growth, and migration in both traditional two-dimensional (2D) and three-dimensional cell (3D) culture models. Biophysical and cell cycle determinations also showed the change in functional cellular biophysical features (cell morphology) and cell cycle kinetic during cancer cell growth induced by the labile iron. According to immunofluorescence and the iron uptake inhibition studies, L-type calcium channel was found to plays a role in the iron uptake in the liver cancer cells. This report gives new insights into iron-mediated cancer cell growth and will pave the new way to diagnosis and treatment of liver cancer.
Similar content being viewed by others
References
Dhar, D., Antonucci, L., Nakagawa, H., Kim, J. Y., Glitzner, E., Caruso, S., Shalapour, S., Yang, L., Valasek, M. A., Lee, S., Minnich, K., Seki, E., Tuckermann, J., Sibilia, M., Zucman-Rossi, J., & Karin, M. (2018). Liver Cancer Initiation Requires p53 Inhibition by CD44-Enhanced Growth Factor Signaling. Cancer Cell, 33, 1061–1077.e1066.
Khosla, R., Rastogi, A., Ramakrishna, G., Pamecha, V., Mukhopadhyay, A., Vasudevan, M., Sarin, S. K., & Trehanpati, N. (2017). EpCAM+ liver cancer stem-like cells exhibiting autocrine Wnt signaling potentially originate in cirrhotic patients. Stem Cells Translational Medicine, 6, 807–818.
Fang, S., Yu, X., Ding, H., Han, J., & Feng, J. (2018). Effects of intracellular iron overload on cell death and identification of potent cell death inhibitors. Biochemical and Biophysical Research Communications, 503, 297–303.
Drakesmith, H., Nemeth, E., & Ganz, T. (2015). Ironing out Ferroportin. Cell Metabolism, 22, 777–787.
Graham, R. M., Chua, A. C., Herbison, C. E., Olynyk, J. K., & Trinder, D. (2007). Liver iron transport. World Journal of Gastroenterology, 13, 4725–4736.
Pantopoulos, K., Porwal, S. K., Tartakoff, A., & Devireddy, L. (2012). Mechanisms of mammalian iron homeostasis. Biochemistry, 51, 5705–5724.
Torti, S. V., & Torti, F. M. (2013). Iron and cancer: more ore to be mined. Nature Reviews Cancer, 13, 342–355.
Babu, K. R., & Muckenthaler, M. U. (2019). miR-148a regulates expression of the transferrin receptor 1 in hepatocellular carcinoma. Scientific Reports, 9, 1518.
Corce, V., Gouin, S. G., Renaud, S., Gaboriau, F., & Deniaud, D. (2016). Recent advances in cancer treatment by iron chelators. Bioorganic & Medicinal Chemistry Letters, 26, 251–256.
Jung, M., Mertens, C., Bauer, R., Rehwald, C., & Brüne, B. (2017). Lipocalin-2 and iron trafficking in the tumor microenvironment. Pharmacological Research, 120, 146–156.
Anderson, E. R., & Shah, Y. M. (2013). Iron homeostasis in the liver, comprehensive. Physiology, 3, 315–330.
Oudit, G. Y., Sun, H., Trivieri, M. G., Koch, S. E., Dawood, F., Ackerley, C., Yazdanpanah, M., Wilson, G. J., Schwartz, A., Liu, P. P., & Backx, P. H. (2003). L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy. Nature Medicine, 9, 1187–1194.
Arjonen, A., Kaukonen, R., & Ivaska, J. (2011). Filopodia and adhesion in cancer cell motility. Cell Adhesion & Migration, 5, 421–430.
Mertens, C., Mora, J., Ören, B., Grein, S., Winslow, S., Scholich, K., Weigert, A., Malmström, P., Forsare, C., Fernö, M., Schmid, T., Brüne, B., & Jung, M. (2018). Macrophage-derived lipocalin-2 transports iron in the tumor microenvironment. Oncoimmunology, 7, e1408751.
Shakoor, A., Zahoor, M., Sadaf, A., Alvi, N., Fadoo, Z., Rizvi, A., Quadri, F., Tipoo, F. A., Khurshid, M., Sajjad, Z., Colan, S., & Hasan, B. S. (2014). Effect of L-type calcium channel blocker (amlodipine) on myocardial iron deposition in patients with thalassaemia with moderate-to-severe myocardial iron deposition: protocol for a randomised, controlled trial. BMJ Open, 4, e005360.
Shindo, M., Torimoto, Y., Saito, H., Motomura, W., Ikuta, K., Sato, K., Fujimoto, Y., & Kohgo, Y. (2006). Functional role of DMT1 in transferrin-independent iron uptake by human hepatocyte and hepatocellular carcinoma cell, HLF. Hepatology Research, 35, 152–162.
Liuzzi, J. P., Aydemir, F., Nam, H., Knutson, M. D., & Cousins, R. J. (2006). Zip14 (Slc39a14) mediates non-transferrin-bound iron uptake into cells. Proceedings National Academy Science USA., 103, 13612–13617.
Gammella, E., Recalcati, S., & Cairo, G. (2016). Dual role of ROS as signal and stress agents: iron tips the balance in favor of toxic effects. Oxidative Medicine and Cellular Longevity, 2016, 8629024.
Fonseca-Nunes, A., Jakszyn, P., & Agudo, A. (2014). Iron and cancer risk–a systematic review and meta-analysis of the epidemiological evidence. Cancer Epidemiology, Biomarkers & Prevention, 23, 12–31.
Acknowledgements
We would like to acknowledge the financial support received from the Center of Excellence on Medical Biotechnology (CEMB), the S&T postgraduate Education and Research Development Office (PERDO), The Commission on Higher Education (CHE), Thailand.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Phiwchai, I., Thongtem, T., Thongtem, S. et al. Liver Cancer Cells Uptake Labile Iron via L-type Calcium Channel to Facilitate the Cancer Cell Proliferation. Cell Biochem Biophys 79, 133–139 (2021). https://doi.org/10.1007/s12013-020-00951-0
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12013-020-00951-0